Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 301 - 325 of 352
MYD88 (WM)
MolecularMYD88 (WM) Methodology Molecular Test Description Genes MYD88 (WM) Disease Waldenström macroglobulinemia (WM), diffuse large B-cell lymphoma (DLBCL) and other B-cell malignancies.MYD88 encodes an adaptor
NPM1
MolecularNPM1 Methodology Molecular Test Description Genes NPM1 Disease AMLNucleophosmin (NPM1) is a multifunctional protein involved in ribosome biogenesis, centrosome duplication, and genomic stability. Mutations
PML-RARA, Quant.
MolecularPML-RARA, Quant. Methodology Molecular Test Description Genes PML-RARA, Quant. Disease Acute promyelocytic leukemia (APL)PML-RARA is a fusion gene resulting from the t(15;17)(q24;q21) translocation, the
SF3B1
MolecularSF3B1 Methodology Molecular Test Description Genes SF3B1 Disease myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL) and other hematologic malignancies. SF3B1 encodes a core component of
Pan-Myeloid Multigene Panel DNA & RNA
MolecularPan-Myeloid Multigene Panel DNA & RNA Methodology Molecular Test Description Genes ABL1, ALK, ANKRD26, ASXL1, BCL2, BCOR, BRAF, CALR, CBL, CCND1, CEBPA, CREBBP, CSF3R, DDX41, DNMT3A, EGFR, ETV6, EZH2,
Pan-Lymphoid Multigene Panel
MolecularPan-Lymphoid Multigene Panel Methodology Molecular Test Description Genes ATM, BTK, BIRC3, CARD11, CD79B, DDX3X, FBXW7, MAPK1, MYD88, NOTCH1, PIK3CA, PIK3CD, PTEN, PTPN6, SF3B1, TP53, XPO Disease chronic
CXCR4 (WM)
MolecularCXCR4 (WM) Methodology Molecular Test Description Genes CXCR4 Disease Waldenström macroglobulinemia (WMCXCR4 encodes a chemokine receptor involved in cell trafficking and survival signaling. Somatic
STAT3 and STAT5B (clonal LGL)
MolecularSTAT3 and STAT5B (clonal LGL) Methodology Molecular Test Description Genes STAT3 and STAT5B Disease large granular lymphocytic (LGL) leukemia STAT3 and STAT5B encode transcription factors that mediate
OncoSwift® Bladder Multi-Omics
MolecularOncoSwift® Bladder Multi-Omics Methodology Molecular Test Description Genes ALK, AKT1, AR, ATM, BAP1, BRAF, BRCA1, BRCA2, CDKN2A, CCND1, CREBBP, EGFR, ERBB2, ERBB3, ERBB4, FANCA, FBXW7, FGFR1, FGFR2,
OncoSwift® Brain Multi-Omics
MolecularOncoSwift® Brain Multi-Omics Methodology Molecular Test Description Genes AKT1, APC, ATM, AXIN2, BRAF, CHEK1, CHEK2, ERBB2, ERBB3, ERBB4, EGFR, FANCA, FBXW7, HRAS, KRAS, MAP2K1, MET, MLH1, MSH2, MSH6,
OncoSwift® Breast Multi-Omics
MolecularOncoSwift® Breast Multi-Omics Methodology Molecular Test Description Genes AR, AKT1, ATM, BRAF, BRCA1, BRCA2, CCNE1, CDH1, CDK12, CHEK1, CHEK2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FANCA, FANCL, FGFR1, FGFR2,
OncoSwift® Colorectal Multi-Omics
MolecularOncoSwift® Colorectal Multi-Omics Methodology Molecular Test Description Genes AKT1, APC, ATM, AXIN2, BRAF, CHEK1, CHEK2, ERBB2, ERBB3, ERBB4, EGFR, FANCA, FBXW7, HRAS, KRAS, MAP2K1, MET, MLH1, MSH2,
OncoSwift® Endometrial Multi-Omics
MolecularOncoSwift® Endometrial Multi-Omics Methodology Molecular Test Description Genes AKT1, APC, ARID1A, ARID2, ATM, BRAF, BRCA1, BRCA2, CDK12, CDK4, CHEK2, CTNNB1, EPCAM, ERBB2, ESR1, FBXW7, KRAS, MDM2, MLH1,
OncoSwift® Esophagus Multi-Omics
MolecularOncoSwift® Esophagus Multi-Omics Methodology Molecular Test Description Genes AKT1, AR, ARAF, ARID1A, BRAF, CDK12, CDK6, CCNE1, CCND1, CDKN2A, EGFR, ERBB2, ERBB3, FGFR1, FGFR2, FGFR3, KIT, KRAS, MCL1,
OncoSwift® Gastric/GIST Multi-Omics
MolecularOncoSwift® Gastric/GIST Multi-Omics Methodology Molecular Test Description Genes AR, APC, ATM, BRAF, CD274, CDH1, CCNE1, CTNNB1, ERBB2, ERBB4, EGFR, FBXW7.FGFR1, FGFR2, FGFR3, KRAS, MET, MDM2, MEN1, MLH1,
OncoSwift® Head and Neck Multi-Omics
MolecularOncoSwift® Head and Neck Multi-Omics Methodology Molecular Test Description Genes AR, ATM, ARAF, BRAF, CD274, CDKN2A, EGFR, ERBB2, ERBB3, FGFR1, FGFR2, FGFR3, HRAS, IDH1, IDH2, KRAS, MET, MTOR, MLH1,
OncoSwift® Liver Multi-Omics
MolecularOncoSwift® Liver Multi-Omics Methodology Molecular Test Description Genes AKT1, ARAF, ARID1A, ATM, BRAF, BAP1, BRCA1, BRCA2, CTNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, GNA11,
OncoSwift® Lung Multi-Omics
MolecularOncoSwift® Lung Multi-Omics Methodology Molecular Test Description Genes AKT1, ALK, ARAF, ATM, BRAF, ARID2, CCND1, CD274, CDK4, CDKN2A, CHEK2, ERBB2, ERBB3, EGFR, FGFR1, FGFR2, FGFR3, HRAS, KEAP1, KRAS,
OncoSwift® Melanoma Multi-Omics
MolecularOncoSwift® Melanoma Multi-Omics Methodology Molecular Test Description Genes APC, ARID2, ATM, BRAF, BAP1, BRCA2, CCND1, CDK4, CDKN2A, CHEK2, CTNNB1, EIF1AX, FBXW7, GNA11, GNAQ, GNAS, IDH1, KIT, MAP2K1,
OncoSwift® Ovarian Multi-Omics
MolecularOncoSwift® Ovarian Multi-Omics Methodology Molecular Test Description Genes AKT1, ARAF, ATM, ARID1A, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CCNE1, CDK12, CHEK1, CHEK2, CTNNB1, ERBB2, ESR1, FGFR1, FGFR2, FGFR3,
OncoSwift® Pancreas Multi-Omics
MolecularOncoSwift® Pancreas Multi-Omics Methodology Molecular Test Description Genes ALK, ATM, BRAF, BRCA1, BRCA2, CDKN2A, ERBB2, FGFR1, FGFR2, FGFR3, FANCL, IDH1, IDH2, KRAS, MLH1, MSH2, MSH6, NRG1, NTRK1, NTRK2,
OncoSwift® Prostate Multi-Omics
MolecularOncoSwift® Prostate Multi-Omics Methodology Molecular Test Description Genes AKT1, AR, ARID1A, ATM, ATR, BARD1, BRAF, BRCA1, BRCA2, BRIP1, CCND1, CDK12, CHEK1, CHEK2, CTNNB1, FANCA, FANCD2, FANCL, HRAS,
OncoSwift® Thyroid Multi-Omics
MolecularOncoSwift® Thyroid Multi-Omics Methodology Molecular Test Description Genes ALK, AKT1, BRAF, BRCA1, BRCA2, CDKN2A, CTNNB1, FGFR1, FGFR2, FGFR3, HRAS, IDH1, IDH2, KRAS, MET, NTRK1, NTRK2, NTRK3, NRAS,
OncoSwift® Tumor of Unknown Origin Multi-Omics
MolecularOncoSwift® Tumor of Unknown Origin Multi-Omics Methodology Molecular Test Description Genes AKT1, ALK, AR, ARAF, BRAF, CD274, CDK4, CDKN2A, CHEK2, CNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2,
MSI
MolecularMSI Methodology Molecular Test Description Genes MSI Disease multiple solid tumors including colorectal, endometrial, and gastric cancersMicrosatellite instability (MSI) is a molecular hallmark of defective
